Latest NewsThe GRE requirement for our MPH program is waived for applicants looking to start in the Fall 2020 semester. Learn more.

Research

The Office of Research is using this space to provide the latest information available from U.S. federal funding agencies in response to the Coronavirus (COVID-19) pandemic.


For the most current information available, we strongly encourage you to please visit ORED’s webpage which is being updated daily and the specific sponsor’s webpage (SPH-relevant sponsors are provided below). You can also find the latest from New Jersey, which informs Rutgers’ implementation of the federal agencies’ guidance here .

COVID-19 UPDATES FROM FEDERAL AGENCIES (an ORED LIST including IMLS, NSF, NASA, USDA, DOE, DOD, DOJ, FDA and more)

Office of Management & Budget Memo - Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus Due to Loss of Operations [March 19, 2020]

General administrative relief, flexibilities and exceptions, which are time-limited to 90 days from the issuance date of the memo and to be reassessed at the end of said timeframe.

National Institutes of Health (NIH):

Deputy Director for Extramural Research, Dr. Mike Lauer, gives a brief overview of NIH changes and flexibilities:



Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding: a new NIH webpage with guidance updated in real time as it becomes available.

  • FAQs are being revised as new questions are received.
  • Includes new NIH COVID funding opportunities.

Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19 [March 16, 2020]

Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 [March 12, 2020]

FYI - THESE ARE IMPORTANT POINTS AND NOT THE FULL NOTICE.

NIH awarding Institutes/Centers (ICs) may request documentation to confirm the requirements of institutional policies.

Pre-Award Costs: NIH is allowing pre-award costs to be incurred from January 20, 2020 through the public health emergency period and prior to the date of a federal award for all applicants and recipients that have been affected by COVID-19.

Extension of Post-Award Financial and Other Reporting: If your institution is unable to complete and submit financial and Research Progress Performance Reports (RPPR) by the scheduled due date, due to the effects of COVID-19, please be sure to contact the assigned grants management and/or program official to let them know the reports will be late. NIH will accept these late reports but will delay issuing grant awards until the reports are received and accepted by the appropriate Institute or Center (IC).

Cost Related Flexibilities/Expenditure of Award Funds

Salaries: NIH understands that many researchers may be unable to work as a result of or related to the effects of COVID-19. If a recipient organization’s policy allows for the charging of salaries and benefits during periods when no work is performed due to the effect of COVID-19, regardless of the funding source, including Federal and non-Federal, then such charges to NIH grant awards will be allowable.

Stipends: Institutions affected by COVID-19 may continue to provide stipend payments to fellows and trainees who may be unable to work as a result of or related to COVID-19. Recipients should notify the assigned grants management official, and provide documentation demonstrating the effect of COVID-19, and how long the institution will be affected.

Travel: Non-refundable costs associated with grant-related travel that has been cancelled due to COVID-19 may be charged to the NIH award if they would have otherwise been allowable. See NIH GPS 7.9.1 for detailed information on the allowability of travel expenses.

Conference Registration Fees: Non-refundable registration fees for conferences, symposiums or seminars that have been cancelled due to COVID19 may be charged to the NIH award if they would have otherwise been allowable (e.g. necessary to accomplish program objectives).

NIH-Supported Meetings and Conferences: Scientific meetings, conferences and workshops supported by NIH funding may be delayed or cancelled due to COVID-19. Non-refundable costs associated with NIH supported meetings and conferences affected by COVID-19 are allowable and may be requested as an administrative supplement to the appropriate funding IC. Recipients should contact their assigned grants management specialist and program official to provide documentation demonstrating the effect of COVID-19. The funding institute or center will work with the recipient to address the impact on the NIH grant.

As this Public Health Emergency continues, recipients may identify additional cost-related flexibilities that are needed. NIH will consider such requests on a case-by-case basis. Contact your assigned grants management specialist and program official to provide a detailed justification outlining the effect of COVID-19 and the flexibility required. NIH will consider such requests in line with the Federal cost principles, NIH policy, and need to support the project.

Extension of Closeout: NIH will allow recipients that are affected by COVID-19 to delay submission of any final financial, performance, and other reports required by the terms and conditions of award for the closeout of expired projects, provided that proper notice about the reporting delay is given by the recipient to the agency. This delay may not exceed one year.

FAQs - Proposal Submission and Award Management Related to COVID-19 [March 10, 2020]

NIH Late Application Policy Due to COVID-19 [March 9, 2020] - Late applications must have a cover letter with explanation of why this application is late

Centers for Disease Control and Prevention (CDC):

Information for CDC Applicants and Recipients of CDC Funding

  • Funding for COVID-19
  • Guidance
  • Relevant Award Terms and Conditions

Novel Coronavirus (COVID-19) General Funding and Grants Frequently Asked Questions (FAQ)

Health Resources & Services Administration (HRSA):

Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions (FAQ)